NEWRON PHARMACEUTICALS SPA (NP5.DE) Stock Analyst Ratings
Europe - FRA:NP5 - IT0004147952 - Common Stock
11.06 EUR
-0.06 (-0.54%)
ChartMill assigns a Buy % Consensus number of 85% to NP5.DE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.11. This target is 63.75% above the current price.
NP5.DE was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about NP5.DE.
In the previous month the buy percentage consensus was at a similar level.
NP5.DE was analyzed by 8 analysts. More opinions would make the average more meaningful.